ArticleThe Lancet. Infectious diseases2023

Safety of monovalent and bivalent BNT162b2 mRNA COVID-19 vaccine boosters in at-risk populations in Israel: a large-scale, retrospective, self-controlled case series study.

Dan Yamin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.